CROI 2020 Abstract eBook
Abstract eBook
Keyword Index
Chest CT 696 Children and adolescents 86, 412, 759, 808, 812, 813, 821, 825, 828, 840, 847 Chimeric antigen receptor 336 Chlamydia trachomatis 1053, 1054 Chloroquine 137 Cholesterol 256, 275 Chromatin 26, 74 Chronic • diseases 869 • hepatitis C 572 • HIV infection 626 • kidney disease 688, 690, 709 • lung disease 86, 415, 742 Circadian 185 Circumcision 211, 212, 1127 Cirrhosis 571, 572, 579 Citrate 402, 685 Cleavage sites 529 Clinical • Appointments 1124 • Outcomes 244, 487, 716, 751 • Pharmacology 449, 498, 841 • Practice guidelines 1119 • Trials 41, 229, 333, 340, 388, 518, 726, 744 Clonal expansion 73, 307, 352, 361, 362, 365, 370, 371, 375, 380 Clonal HIV populations 366, 370 Clustering 920, 929 Clusters 907, 911, 919, 926, 927, 929 CMV 270, 753 CNS escape 424 CNS 437 Cocaine 417 Cognition 417, 649 Cognitive impairment 397, 408, 415, 416, 417, 837 Cohorts study 303, 486, 491, 523, 580, 626, 659, 708, 712, 725, 816, 852, 870, 877, 891, 895, 896, 1022 Coinfection 242, 561, 571, 572, 590, 731, 748, 756, 880, 1049
CyTOF 215, 371 Cytokines 220, 243, 260, 270, 382, 612, 747, 794, 1064, 1066 Cytomegalovirus (CMV) 73, 204, 232, 236, 296, 672, 752 Cytotoxicity 268 -D-
Early infant diagnosis 132, 133, 782, 785, 786 Early treatment 808 EASL risk score 547 East Africa 45, 865 Eastern Europe 595 Ebola vaccine 264
Daily caloric intake 675 Darunavir 441, 480, 493 Data • Analysis 1100 • Collection 1100 • Fusion 397 • Visualization 220 Data-to-care 46 DC targeting 293, 295 D-dimer 195, 240 DdPCR 311, 374, 812 Death 559 Decision-support 1119 Decompensation 585 Deep sequencing 328, 928 Defaulter 1105
Echocardiogram 654, 700 Economic evaluation 961 Education 1119 EEG 390 Efavirenz 82, 456, 460, 475, 514, 548, 771, 821, 1057, 1120 Efficacy 447 Eicosanoids 796 Elite controller 40, 74, 192, 232, 241, 248, 267, 269, 365, 381 Elite suppressor 378 Emergency department 860, 966, 1121, 1125, 1138 Emphysema 699 Emtricitabine (FTC) 443, 445, 509 Encephalitis 425 Ending the HIV Epidemic (EHE) 866, 903, 904, 941, 1009, 1092, 1096, 1143 Endothelial activation 589, 795 Endothelial dysfunction 666, 795, 830 End-stage renal disease 558, 690 Engagement in care 45, 131, 1101, 1102, 1110 Entry inhibition 527 Env 383, 527, 535 Env-specific B cells 291, 292 Epidemiology 521, 556, 568, 601, 700, 825, 870, 920, 1047 Epigenetics 253, 273, 305, 704, 714, 823
Delayed diagnosis 240 Dementia 403, 414, 439 Dendritic cells 171, 282, 292 Depot medroxyprogesterone acetate (DMPA) 471, 1065 Depression 413, 414, 439, 475, 666, 684, 701, 832, 833, 896, 897 Device acceptability 497 Diabetes 81, 671, 672, 680, 682, 683, 684, 685, 687 Diagnosis 421, 750, 761, 762, 784, 974, 1125 Diagnostic tests 743, 761, 966 Diet 667 Differentiated ART delivery models 43, 131, 1088, 1111, 1112, 1115, 1116, 1117, 1118 Differentiated care 45, 1088, 1110, 1111, 1112, 1113, 1115, 1116 Diffusion tensor imaging 399, 400 Dipeptides 248 Direct-acting antiviral (DAA) 122, 449, 557, 565, 568, 570, 581, 582, 586, 588, 589, 596 • Failure 563 • Therapy 563, 571, 572, 578, 579, 583, 585 Direction of transmission 930 Discontinuation 488 Discordant 950 Disease progression 189 Disparities 643, 656, 866, 1007, 1009 Dispensing 499 Diversity 204, 325, 319, 377, 934 DNA 135, 217, 288, 312, 367, 373, 374, 377, 502, 714, 812, 813 • methylation 714 • reservoir 135 Dolutegravir 25, 35, 81, 82, 129, 130, 298, 436, 442, 450, 451, 467, 475, 477, 480, 483, 484, 485, 489, 490, 491, 492, 493, 495, 514, 540, 677, 678, 679, 681, 771, 772, 789, 790, 792, 827, 847, 1120 Dominican Republic 537 Doravirine 462, 531 Douche 1067 DREAMS 94 Dried blood spots 125, 444, 446, 497, 520, 969, 1003, 1085 Droplet digital PCR 347 Drug • concentrations 451 • discovery 505 • induced liver injury 741 • interactions 447, 448, 449, 451, 471, 733, 735 • resistance 179, 507, 510, 512, 524, 528, 530, 531, 533, 534, 535, 536, 539, 736, 931, 932 Drug-drug interactions 129 Drug-resistant tuberculosis 736, 738 Dual infection 325
Epstein-Barr virus 68, 256 Eradication 349, 357, 386 Erectile dysfunction drugs 877 Estimated glomerular filtration rate 688, 1004 Etonogestrel implant 129 Etravirine 494 Evaluation 1016 Event-driven PrEP 1031 Evolution 179, 189, 424 Exceptional Elite Controllers 192, 267
Combination HIV interventions 1093 Combination prevention 149, 1129 Combinectin 20 Community • ART 1117 • health centers 1022 • health workers 44 • pharmacy 1114 • testing 955 • -based HIV testing and counseling 142
Executive function 832 Exercise 238, 393, 704 Exhaustion 247 Exosomes 216Exposed uninfected children 786, 798, 799, 800, 801, 803, 804, 832 Exposure-response 462, 463 External validation 688
Extracellular vesicles 357, 408, 584 Extrahepatic manifestations 557 Eye disorder 418 -F- False discovery rate 401 False positive 966 Fast-track city 1100 Fat 667, 674, 705 Fatigue 416 Fatty liver 547 Fecal calprotectin 239 Fecal microbiome 225 Female genital tract 215, 226, 1062 Female sex workers 853 Ferritin 691 Ferroptosis 65 FGF-21 640 FIB-4 544 Fibrosis 277, 547, 614 Fiebig stage 476 Financing 1091 First 90 940 Flow cytometry 209, 385, 481 Flt3L 203 Follicular dendritic cell 191
• -based intervention 984 • -based monitoring 1080 Comorbidity 84, 85, 151, 245, 664, 699, 708, 710, 712, 872, 1091 Compartmentalization 188, 317, 425, 426 Complement activity 286 Complementation 179 Condom use 1127
Condomless sex 1067 Conjunctival cancer 69 Contraception 1056, 1057, 1059, 1063, 1066 Controlled attenuation parameter 541 Controllers 258, 592 COPD 699 Cord blood 796, 802 CoRIS 511 Coronal sulcus 211 Coronary artery disease 643, 651, 656
Keyword Index
Coronary stenosis 635 Cost analysis 965, 1087 Cost-effectiveness 556, 665, 777, 785, 818, 953, 962, 1011, 1012, 1089, 1090, 1093, 1094, 1129, 1144 Couples 859 CRISPR-Cas9 22, 174, 349, 350, 353, 369 Cross- sectional surveys 889 Cryptococcal antigemia 746 Cryptococcal antigen 743, 745 Cryptococcal meningitis 426, 743, 744, 747, 748, 756 Cryptococcosis 747 CSF1R 420 CTL escape 365, 381 Cure 37, 39, 76, 192, 200, 306, 311, 312, 339, 346, 348, 350, 359, 374 CX3CR1 672, 673
Dual reporter virus with protein barcodes 166 Dual therapy 435, 487, 490, 492, 494, 677, 679 Dual-energy X-ray absorptiometry 820, 821 Durable viral suppression 1116 Dynamic HIV transmission model 1093 Dysbiosis 223, 225 Dyspnoe 654 -E- Early ART 135, 136, 206, 347, 476, 1139 Early bactericidal activity 732 Early HIV • detection 1139 • diagnosis 646, 1139 • infection 1139
Food insecurity 1132 Foreskin 209, 210, 212 Fostemsavir 503 Frailty 270, 402, 416, 542, 707 FTY720 119 Full-length sequencing 324, 368, 376, 561, 811 Functional connectivity 397 Fusion 177 -G-
CXCL10 440 CXCR5 200 CYP2B6 82 CYP3A4 450 CyPA 165
Gag 269, 529 Gait 683, 706 Galectin-9 386
CROI 2020 463
Made with FlippingBook - professional solution for displaying marketing and sales documents online